Mounting evidences recommend a fundamental role for RNA metabolism in ALS pathogenesis [4,5,6], supported by the most recent identification of mutations in TAR DNA binding protein 43 (TDP-43) and Fused-In-Sarcoma (FUS) genes as pathological hallmarks of the disease [2,7]. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.